FnuSidraMDF.A.C.E.(She/Her)
Endocrinology • Macon, GAAdrenal Disease, Parathyroid, Thyroid
Endocrinology Consultant, The Jones center for Diabetes and Endocrine Wellness, Macon, GA
Dr. Sidra is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
265 Sheraton Blvd
Macon, GA 31210Phone+1 478-746-8626
Summary
- Dr. Fnu Sidra is an endocrinologist in Macon, GA. She received her medical degree from King Edward Medical University, completed internal medicine residency from Saint Mary’s Hospital, CT, completed fellowship from UT Southwestern Medical Center, Dallas Texas. She specializes in adrenal disease, thyroid and parathyroid disorders.
Education & Training
University of Texas Southwestern Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 2021 - 2023
St Mary's Hospital (Waterbury)Residency, Internal Medicine, 2018 - 2021
King Edward Medical UniversityClass of 2016
Certifications & Licensure
GA State Medical License 2022 - 2026
CT State Medical License 2018 - 2021
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Texas medical boardPhysician in training license
Awards, Honors, & Recognition
- Chief Fellow UT Southwestern Medical Center, 2022
- Fellow Patient Care Award UT Southwestern Medical center, 2022
- Outstanding Intern of the Year Saint Mary’s Hospital, 2019
Publications & Presentations
PubMed
- Healthcare utilization, mortality, and cardiovascular events following GLP1-RA initiation in chronic kidney disease.Shuyao Zhang, Fnu Sidra, Carlos A Alvarez, Mustafa Kinaan, Ildiko Lingvay
Nature Communications. 2024-12-05
Journal Articles
- Glucagon-like Peptide-1 receptor agonists versus dipeptidyl-peptidase 4 inhibitors in advanced chronic kidney disease and end stage kidney disease: Real world effectiv...N.U. Sidra a , Shubham Agarwal a , Paola Lockhart Pastor a , Donglu Xie b , Xilong Li c , Ildiko Lingvay a c, Journal of Diabetes and its Complications, 1/1/2025
Authored Content
- Glucagon-like Peptide-1 receptor agonists versus dipeptidyl-peptidase 4 inhibitors in advanced chronic kidney disease and end stage kidney disease: Real world effectiveness and persistence of therapyJanuary 2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
